Chemoinformaics analysis of 4-METHYL-3-CYCLOHEXENOL
Molecular Weight | 112.172 | nRot | 0 |
Heavy Atom Molecular Weight | 100.076 | nRig | 6 |
Exact Molecular Weight | 112.089 | nRing | 1 |
Solubility: LogS | -1.384 | nHRing | 0 |
Solubility: LogP | 1.877 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 20.4935 |
nHD | 1 | BPOL | 12.0385 |
QED | 0.47 |
Synth | 3.188 |
Natural Product Likeliness | 3.119 |
NR-PPAR-gamma | 0.026 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.329 |
HIA | 0.009 |
CACO-2 | -4.285 |
MDCK | 0.0000351 |
BBB | 0.924 |
PPB | 0.575259 |
VDSS | 1.237 |
FU | 0.428043 |
CYP1A2-inh | 0.311 |
CYP1A2-sub | 0.469 |
CYP2c19-inh | 0.05 |
CYP2c19-sub | 0.745 |
CYP2c9-inh | 0.011 |
CYP2c9-sub | 0.568 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.295 |
CYP3a4-inh | 0.01 |
CYP3a4-sub | 0.178 |
CL | 13.009 |
T12 | 0.769 |
hERG | 0.011 |
Ames | 0.018 |
ROA | 0.024 |
SkinSen | 0.747 |
Carcinogencity | 0.941 |
EI | 0.989 |
Respiratory | 0.054 |
NR-Aromatase | 0.006 |
Antiviral | No |
Prediction | 0.952857 |